Cargando…
Sustained effects of single doses of classical psychedelics in humans
The serotonergic classical psychedelics include compounds that primarily activate the brain’s serotonin 2 A receptor (5-HT2AR), such as LSD, psilocybin, and DMT (ayahuasca). The acute effects of these compounds are well-known as are their ability to increase the emotional state both in healthy peopl...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700827/ https://www.ncbi.nlm.nih.gov/pubmed/35729252 http://dx.doi.org/10.1038/s41386-022-01361-x |
_version_ | 1784839397564219392 |
---|---|
author | Knudsen, Gitte M. |
author_facet | Knudsen, Gitte M. |
author_sort | Knudsen, Gitte M. |
collection | PubMed |
description | The serotonergic classical psychedelics include compounds that primarily activate the brain’s serotonin 2 A receptor (5-HT2AR), such as LSD, psilocybin, and DMT (ayahuasca). The acute effects of these compounds are well-known as are their ability to increase the emotional state both in healthy people and in those with neuropsychiatric disorders. In particular psilocybin, the psychoactive constituent in “magic mushrooms”, has shown great potential for treatment of anxiety and depression. A unique and compelling feature of psychedelics is that intake of just a single psychedelic dose is associated with long-lasting effects. This includes effects on personality, e.g., higher openness, and amelioration of depressive symptoms. This review focuses on these stunning effects and summarizes our current knowledge on which behavioral, biochemical, neuroimaging, and electrophysiological data support that the intriguing effects of psychedelics on the human brain and mind are based on neural plasticity. The review also points to so far understudied areas and suggests research questions to be addressed in future studies which potentially can help to understand the intriguing long-term effects after intake of a single (or a few) psychedelic doses. |
format | Online Article Text |
id | pubmed-9700827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-97008272022-11-27 Sustained effects of single doses of classical psychedelics in humans Knudsen, Gitte M. Neuropsychopharmacology Review Article The serotonergic classical psychedelics include compounds that primarily activate the brain’s serotonin 2 A receptor (5-HT2AR), such as LSD, psilocybin, and DMT (ayahuasca). The acute effects of these compounds are well-known as are their ability to increase the emotional state both in healthy people and in those with neuropsychiatric disorders. In particular psilocybin, the psychoactive constituent in “magic mushrooms”, has shown great potential for treatment of anxiety and depression. A unique and compelling feature of psychedelics is that intake of just a single psychedelic dose is associated with long-lasting effects. This includes effects on personality, e.g., higher openness, and amelioration of depressive symptoms. This review focuses on these stunning effects and summarizes our current knowledge on which behavioral, biochemical, neuroimaging, and electrophysiological data support that the intriguing effects of psychedelics on the human brain and mind are based on neural plasticity. The review also points to so far understudied areas and suggests research questions to be addressed in future studies which potentially can help to understand the intriguing long-term effects after intake of a single (or a few) psychedelic doses. Springer International Publishing 2022-06-21 2023-01 /pmc/articles/PMC9700827/ /pubmed/35729252 http://dx.doi.org/10.1038/s41386-022-01361-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Article Knudsen, Gitte M. Sustained effects of single doses of classical psychedelics in humans |
title | Sustained effects of single doses of classical psychedelics in humans |
title_full | Sustained effects of single doses of classical psychedelics in humans |
title_fullStr | Sustained effects of single doses of classical psychedelics in humans |
title_full_unstemmed | Sustained effects of single doses of classical psychedelics in humans |
title_short | Sustained effects of single doses of classical psychedelics in humans |
title_sort | sustained effects of single doses of classical psychedelics in humans |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700827/ https://www.ncbi.nlm.nih.gov/pubmed/35729252 http://dx.doi.org/10.1038/s41386-022-01361-x |
work_keys_str_mv | AT knudsengittem sustainedeffectsofsingledosesofclassicalpsychedelicsinhumans |